# Mifepristone in Children With Refractory Cushing's Disease

> **NCT01925092** · PHASE3 · WITHDRAWN · sponsor: **Corcept Therapeutics**

## Conditions studied

- Cushing's Disease

## Interventions

- **DRUG:** mifepristone

## Key facts

- **NCT ID:** NCT01925092
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2014-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925092, "Mifepristone in Children With Refractory Cushing's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01925092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*